As the new cases and related deaths fall in sub-Saharan Africa, the virus is rearing its head elsewhere. What's the cause?

Merck's experimental two-drug combination met the main goal of significantly suppressing replication of the HIV-1 virus in ...

Gilead Sciences will no longer provide four HIV medicines for free as part of a patient assistance program starting at the ...

More than 1 million Americans live with human immunodeficiency virus, or HIV, with tens of thousands of new diagnoses each ...

The NACA boss said this while urging Nigerians to prioritise their health by knowing their HIV status, especially as the ...

The movie, premiering this month, is based on real events in the early 1990s, when a group of young people in Cuba were ...

As we mark the holidays, here are a few of the many heroes who are working to build a stronger global health future by ...

A new long-acting preventive HIV drug could reach the world’s poorest countries by the end of 2025 or early 2026, a global ...

The number of HIV patients in Florida has steadily climbed over the past five years. During HIV/AIDS Awareness Month, ...

Darwin Tenoria first learned about HIV when he was on his deathbed. He was 27 and weighed just 70 pounds. "I died for two minutes and I was revived in the hospital," he remembers. When he woke up ...

U.S. drugmaker Merck said on Thursday its experimental combination treatment for some adults with HIV-1 infection met the ...